Population dynamics of an RNA virus and its defective interfering particles in passage cultures

Virology Journal

Volumn 7, Issue , 2010, Pages

  Thompson, Kristen A Stauffer ^a   Yin, John ^a  

^a University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL STRAIN BHK; DEFECTIVE INTERFERING PARTICLE; MATHEMATICAL MODEL; MICROBIAL POPULATION DYNAMICS; NONHUMAN; PLAQUE FORMING CELL; RNA VIRUS; STEADY STATE; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CELL CULTURE; DEFECTIVE VIRUS; GROWTH, DEVELOPMENT AND AGING; HAMSTER; THEORETICAL MODEL; VIRUS LOAD;

RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

ANIMALS; CELLS, CULTURED; CRICETINAE; DEFECTIVE VIRUSES; MODELS, THEORETICAL; PLAQUE ASSAY; SERIAL PASSAGE; VESICULOVIRUS; VIRAL LOAD; VIRUS CULTIVATION;

EID: 77958062791     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-257     Document Type: Article

References (41)

1. Interference of inactive virus with the propagation of virus of influenza. W Henle G Henle, Science 1943 98 87 89 10.1126/science.98.2534.87 17749157
2. Incomplete Forms of Influenza Virus. P von Magnus, Advances in Virus Research 1954 2 59 79 full-text 13228257
3. Defective viral particles and viral disease processes. AS Huang D Baltimore, Nature 1970 226 5243 325 327 10.1038/226325a0 5439728
4. The origins of defective interfering particles of the negative-strand RNA viruses. RA Lazzarini JD Keene M Schubert, Cell 1981 26 2 Pt 2 145 154 10.1016/0092-8674(81)90298-1 7037195
5. Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. L Roux AE Simon JJ Holland, Adv Virus Res 1991 40 181 211 full-text 1957718
6. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. WJ Bean Y Kawaoka JM Wood JE Pearson RG Webster, J Virol 1985 54 1 151 160 3973976
7. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. A Meyerhans R Cheynier J Albert M Seth S Kwok J Sninsky L Morfeldt-Manson B Asjo S Wain-Hobson, Cell 1989 58 5 901 910 10.1016/0092-8674(89)90942-2 2550139
8. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. J Aaskov K Buzacott HM Thu K Lowry EC Holmes, Science 2006 311 5758 236 238 10.1126/science.1115030 16410525
9. A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread. B Dropulic M Hermankova PM Pitha, Proc Natl Acad Sci USA 1996 93 20 11103 11108 10.1073/pnas.93.20.11103 8855316
10. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. MH Malim S Bohnlein J Hauber BR Cullen, Cell 1989 58 1 205 214 10.1016/0092-8674(89)90416-9 2752419
11. Defective interfering viruses and their potential as antiviral agents. AC Marriott NJ Dimmock, Rev Med Virol 2010 20 1 51 62 10.1002/rmv.641 20041441
12. Interferon induction by viruses. VIII. Vesicular stomatitis virus: [+/-]DI-011 particles induce interferon in the absence of standard virions. MJ Sekellick PI Marcus, Virology 1982 117 1 280 285 10.1016/0042-6822(82)90530-X 6175087
13. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles. JS Yount L Gitlin TM Moran CB Lopez, J Immunol 2008 180 7 4910 4918 18354215
14. Evolutionary transition toward defective RNAs that are infectious by complementation. J Garcia-Arriaza SC Manrubia M Toja E Domingo C Escarmis, J Virol 2004 78 21 11678 11685 10.1128/JVI.78.21.11678-11685.2004 15479809
15. A segmented form of foot-and-mouth disease virus interferes with standard virus: a link between interference and competitive fitness. J Garcia-Arriaza E Domingo C Escarmis, Virology 2005 335 2 155 164 10.1016/j.virol.2005.02.012 15840515
16. Dynamics of mutation and recombination in a replicating population of complementing, defective viral genomes. J Garcia-Arriaza S Ojosnegros M Davila E Domingo C Escarmis, J Mol Biol 2006 360 3 558 572 10.1016/j.jmb.2006.05.027 16797586
17. New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines. T Rodriguez-Calvo S Ojosnegros M Sanz-Ramos J Garcia-Arriaza C Escarmis E Domingo N Sevilla, PLoS One 5 4 10414 10.1371/journal.pone.0010414 20454676
18. Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles. NJ DePolo C Giachetti JJ Holland, J Virol 1987 61 2 454 464 3027375
19. Toward antiviral strategies that resist viral escape. D Endy J Yin, Antimicrob Agents Chemother 2000 44 4 1097 1099 10.1128/AAC.44.4.1097-1099.2000 10722522
20. Quantitative analysis of a parasitic antiviral strategy. H Kim J Yin, Antimicrobial Agents & Chemotherapy 2004 48 3 1017 1020
21. Defective interfering particles: effects in modulating virus growth and persistence. CR Bangham TB Kirkwood, Virology 1990 179 2 821 826 10.1016/0042-6822(90)90150-P 2238471
22. Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. TB Kirkwood CR Bangham, Proc Natl Acad Sci USA 1994 91 18 8685 8689 10.1073/pnas.91.18.8685 8078942
23. Co-operation and defection: playing the field in virus dynamics. E Szathmary, J Theor Biol 1993 165 3 341 356 10.1006/jtbi.1993.1193 8114502
24. Natural selection and dynamical coexistence of defective and complementing virus segments. E Szathmary, J Theor Biol 1992 157 3 383 406 10.1016/S0022-5193(05)80617-4 1465021
25. Within-host spatial dynamics of viruses and defective interfering particles. SA Frank, J Theor Biol 2000 206 2 279 290 10.1006/jtbi.2000.2120 10966764
26. Modeling defective interfering virus therapy for AIDS: conditions for DIV survival. GW Nelson AS Perelson, Math Biosci 1995 125 2 127 153 10.1016/0025-5564(94)00021-Q 7881191
27. Defective Interfering Rhabdoviruses. JJ Holland, The Rhabdoviruses New York: Plenum Press, Wagner RR, 1987 297 360
28. Multiple-hit inhibition of infection by defective interfering particles. KA Stauffer Thompson GA Rempala J Yin, J Gen Virol 2009 90 Pt 4 888 899 10.1099/vir.0.005249-0 19264636
29. Gene rearrangement attenuates expression and lethality of a nonsegmented negative strand RNA virus. G Wertz V Perepelitsa L Ball, Proc Natl Acad Sci USA 1998 95 7 3501 3506 10.1073/pnas.95.7.3501 9520395
30. Some properties of the transmissible interfering component of vesicular stomatitis virus preparations. AJ Bellett PD Cooper, J Gen Microbiol 1959 21 498 509 13798559
31. An introduction to the bootstrap. B Efron R Tibshirani, New York: Chapman & Hall 1993
32. Cyclic production of vesicular stomatitis virus caused by defective interfering particles. EL Palma A Huang, J Infect Dis 1974 129 4 402 410 4361583
33. Viral genome synthesis in BHK 21 cells persistently infected with Sendai virus. L Roux JJ Holland, Virology 1980 100 1 53 64 10.1016/0042-6822(80)90551-6 6243201
34. Presence of a truncated form of the Sendai virus P protein in a long-term persistent infection: implications for the maintenance of the persistent state. D Garcin M De Melo L Roux D Kolakofsky J Curran, Virology 1994 201 1 19 25 10.1006/viro.1994.1261 8178486
35. Periodic Mortality Events in Predator-Prey Systems. A Ives K Gross V Jansen, Ecology 2000 81 12 3330 3340
36. Factors involved in the generation and replication of rhabdovirus defective T particles. JJ Holland LP Villarreal M Breindl, J Virol 1976 17 3 805 815 176445
37. Quantitative studies on adsorption, elution, and haemagglutination of vesicular stomatitis virus. P Arstila, Arch Virol 1976 51 1-2 51 58 10.1007/BF01317833 183632
38. Viral interference by defective particles of vesicular stomatitis virus measured in individual cells. MJ Sekellick PI Marcus, Virology 1980 104 1 247 252 10.1016/0042-6822(80)90385-2 6249028
39. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. S Noble L McLain NJ Dimmock, Vaccine 2004 22 23-24 3018 3025 10.1016/j.vaccine.2004.02.013 15297051
40. Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. A Mann AC Marriott S Balasingam R Lambkin JS Oxford NJ Dimmock, Vaccine 2006 24 20 4290 4296 10.1016/j.vaccine.2006.03.004 16621180
41. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. NJ Dimmock EW Rainsford PD Scott AC Marriott, J Virol 2008 82 17 8570 8578 10.1128/JVI.00743-08 18579602